Study finds tPA safe for stroke patients with sickle cell disease | Zika virus tied to eye problems in infants | Scientist awarded $2.7M for infectious disease study
April 20, 2017
AABB SmartBrief
News for the transfusion medicine and cellular therapy community
Top Story
Study finds tPA safe for stroke patients with sickle cell disease
Patients with sickle cell disease who have strokes can be safely treated with tissue plasminogen activator, according to a study by Medical University of South Carolina researchers. The findings were based on data for 2,016,652 patients treated in hospitals from 2008 to 2015, and no significant differences were seen in rates of tPA use or in-hospital complications.
ScienceDaily (4/11) 
LinkedIn Twitter Facebook Google+ Email
Immucor Launches NEW Validation Panel!
Validating a new blood bank instrument? As part of our commitment to the blood bank industry, Immucor is pleased to announce the availability of a new Validation Panel to supplement your validation studies. Let us help ease the burden of sourcing those difficult to find positive antibody screen samples! For more information please call 800.855.IMMUCOR. Click Here.
Science & Health
Zika virus tied to eye problems in infants
Of 43 infants with Zika-related microcephaly in Colombia and Venezuela, 88% and 12% developed macular or optic nerve abnormalities and congenital glaucoma, respectively, according to a study in JAMA Ophthalmology. The results should prompt evaluations for ophthalmic findings for all babies with Zika-linked microcephaly, researchers said.
Physician's Briefing/HealthDay News (4/18) 
LinkedIn Twitter Facebook Google+ Email
Emerging Trends
Scientist awarded $2.7M for infectious disease study
The European Research Council has awarded a grant worth $2.7 million to a Goethe University Frankfurt scientist. Ivan Dikic is examining the role the ubiquitin system has in bacterial infections in order to develop new ways to fight infectious diseases.
Drug Target Review (U.K.) (4/18) 
LinkedIn Twitter Facebook Google+ Email
Industry News & Practice
GenDx, S. Korean company enter distribution deal for HLA assays
GenDx has reached an agreement with South Korean firm Infopia to distribute Infopia's GeneFinder human leukocyte antigen real-time PCR assays in Europe for undisclosed terms. GenDx will sell the kits through its local distributor network.
360Dx (tiered subscription model) (4/18) 
LinkedIn Twitter Facebook Google+ Email
RBC Transfusion Guidelines on a Quick, Handy Card
New from AABB Publications, the RBC Transfusion Data Card is compliant with the new RBC Clinical Practice Guidelines released by AABB and published in JAMA. This practical reference folds down to fit a pocket and contains evidence-based restrictive strategies for Red Blood Cell (RBC) transfusion in both adult and pediatric patients. Order for you and your staff today!
Government & Regulatory
WHO readies vector control plan
The World Health Organization is finalizing a global vector control plan for approval by the World Health Assembly in May. The plan is focused on densely urban areas that can be breeding grounds for Aedes mosquitoes.
New Scientist (free content) (4/18) 
LinkedIn Twitter Facebook Google+ Email
Association News
"AABB News" highlights pediatric care
The treatment of pediatric patients often requires specific care that may differ from the treatment of adult patients. The April issue of "AABB News" focuses on pediatric care -- specifically as it relates to the fields of transfusion medicine and cellular therapies. Four articles written by AABB members with expertise in pediatric care highlight various aspects of pediatric transfusion medicine and cellular therapies. The topics include the use of technology to improve patient care, red blood cell transfusions in neonates, clinical data in pediatric transfusion medicine and pediatric patient blood management.
LinkedIn Twitter Facebook Google+ Email
Learn more about AABB®:
Homepage | Join AABB | Conferences
Marketplace | AABB CareerLink
powered by
Contact Center Manager
Center Director
Money doesn't change men. It merely unmasks them.
Henry Ford,
LinkedIn Twitter Facebook Google+ Email
Sign Up
SmartBrief offers 200+ newsletters
Subscriber Tools:
Contact Us:
Advertising  -  Christopher Black
Editor  -  Tom Parks
Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004
© 1999-2017 SmartBrief, Inc.®
Privacy policy |  Legal Information